Ohio Public Employees Retirement System (OPERS)
KALV

Ohio Public Employees Retirement System (OPERS)’s KalVista Pharmaceuticals KALV Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,100
Closed -$9K – 1995
2023
Q1 		$9K Buy
+1,100
New +$8.21K ﹤0.01% 1931
2021
Q1 		– Sell
-278
Closed -$5K – 1990
2020
Q4 		$5K Buy
+278
New +$4.77K ﹤0.01% 1936

Other funds holding KALV

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s KALV Position: Q2 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of KalVista Pharmaceuticals (KALV) in Q2 2023, closing a stake of 1,100 shares — an estimated $9K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in KALV in Q4 2020 and held it in 2 quarters. The position peaked at $9K in Q1 2023. 94 funds tracked by Wall St. Rank hold KALV as of Q2 2023.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining KalVista Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 1,100 KalVista Pharmaceuticals shares in Q2 2023, an estimated $9K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in KalVista Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s KalVista Pharmaceuticals position peaked at $9K in Q1 2023.
  • 94 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2023, filed 15 Aug 2023.